Evaluation of the efficacy and safety of a CS20® protective barrier gel containing OGT compared with topical aciclovir and placebo on functional and objective symptoms of labial herpes recurrences: a randomized clinical trial
Identifieur interne : 000083 ( France/Analysis ); précédent : 000082; suivant : 000084Evaluation of the efficacy and safety of a CS20® protective barrier gel containing OGT compared with topical aciclovir and placebo on functional and objective symptoms of labial herpes recurrences: a randomized clinical trial
Auteurs : A. Khemis [France] ; L. Duteil [France] ; A. C. Coudert [France] ; Y. Tillet [France] ; O. Dereure [France] ; J. P. Ortonne [France]Source :
- Journal of the European Academy of Dermatology and Venereology [ 0926-9959 ] ; 2012-10.
English descriptors
- KwdEn :
- Aciclovir, Aciclovir group, Acyclovir, Acyclovir cream, Antimicrob agents chemother, Antiviral, Antiviral activity, Authors journal, Baseline, Clinical scores, Dermatology, Endpoint, European academy, Functional symptoms, Herpes, Herpes episode, Herpes labialis, Herpes simplex labialis, Intensity score, Jeadv, Labial, Labial herpes, Labial recurrences, Labialis, Lesion, Lesion repair, Oedema, Oral lubricant solution, Oxygenated glycerol triesters, Pain intensity score, Penciclovir, Penciclovir cream, Percentage reduction, Placebo, Placebo group, Protective barrier, Randomized, Recurrence, Recurrent herpes labialis, Recurrent labial herpes, Secondary endpoints, Simplex, Subjective scores, Time point, Topical, Topical aciclovir, Topical aciclovir group, Topical therapy, Treatment groups, Unsightly appearance, Venereology, Venereology khemis.
- Teeft :
- Aciclovir, Aciclovir group, Acyclovir, Acyclovir cream, Antimicrob agents chemother, Antiviral, Antiviral activity, Authors journal, Baseline, Clinical scores, Dermatology, Endpoint, European academy, Functional symptoms, Herpes, Herpes episode, Herpes labialis, Herpes simplex labialis, Intensity score, Jeadv, Labial, Labial herpes, Labial recurrences, Labialis, Lesion, Lesion repair, Oedema, Oral lubricant solution, Oxygenated glycerol triesters, Pain intensity score, Penciclovir, Penciclovir cream, Percentage reduction, Placebo, Placebo group, Protective barrier, Randomized, Recurrence, Recurrent herpes labialis, Recurrent labial herpes, Secondary endpoints, Simplex, Subjective scores, Time point, Topical, Topical aciclovir, Topical aciclovir group, Topical therapy, Treatment groups, Unsightly appearance, Venereology, Venereology khemis.
Abstract
Background Topical or systemic antiviral drugs reduce the duration of herpes simplex virus 1 (HSV‐1) recurrences but may not alleviate functional symptoms.
Url:
DOI: 10.1111/j.1468-3083.2011.04269.x
Affiliations:
- France
- Languedoc-Roussillon, Occitanie (région administrative), Provence-Alpes-Côte d'Azur, Île-de-France
- Montesson, Montpellier, Nice
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000A06
- to stream Istex, to step Curation: 000A06
- to stream Istex, to step Checkpoint: 000F90
- to stream Main, to step Merge: 003B37
- to stream Main, to step Curation: 003B20
- to stream Main, to step Exploration: 003B20
- to stream France, to step Extraction: 000083
Links to Exploration step
ISTEX:1450E6DD7D7326D61875E2B7F534873A886626BCLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Evaluation of the efficacy and safety of a CS20® protective barrier gel containing OGT compared with topical aciclovir and placebo on functional and objective symptoms of labial herpes recurrences: a randomized clinical trial</title>
<author><name sortKey="Khemis, A" sort="Khemis, A" uniqKey="Khemis A" first="A." last="Khemis">A. Khemis</name>
</author>
<author><name sortKey="Duteil, L" sort="Duteil, L" uniqKey="Duteil L" first="L." last="Duteil">L. Duteil</name>
</author>
<author><name sortKey="Coudert, A C" sort="Coudert, A C" uniqKey="Coudert A" first="A. C." last="Coudert">A. C. Coudert</name>
</author>
<author><name sortKey="Tillet, Y" sort="Tillet, Y" uniqKey="Tillet Y" first="Y." last="Tillet">Y. Tillet</name>
</author>
<author><name sortKey="Dereure, O" sort="Dereure, O" uniqKey="Dereure O" first="O." last="Dereure">O. Dereure</name>
</author>
<author><name sortKey="Ortonne, J P" sort="Ortonne, J P" uniqKey="Ortonne J" first="J. P." last="Ortonne">J. P. Ortonne</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:1450E6DD7D7326D61875E2B7F534873A886626BC</idno>
<date when="2012" year="2012">2012</date>
<idno type="doi">10.1111/j.1468-3083.2011.04269.x</idno>
<idno type="url">https://api.istex.fr/document/1450E6DD7D7326D61875E2B7F534873A886626BC/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000A06</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000A06</idno>
<idno type="wicri:Area/Istex/Curation">000A06</idno>
<idno type="wicri:Area/Istex/Checkpoint">000F90</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000F90</idno>
<idno type="wicri:doubleKey">0926-9959:2012:Khemis A:evaluation:of:the</idno>
<idno type="wicri:Area/Main/Merge">003B37</idno>
<idno type="wicri:Area/Main/Curation">003B20</idno>
<idno type="wicri:Area/Main/Exploration">003B20</idno>
<idno type="wicri:Area/France/Extraction">000083</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">Evaluation of the efficacy and safety of a CS20<hi rend="superscript">®</hi>
protective barrier gel containing OGT compared with topical aciclovir and placebo on functional and objective symptoms of labial herpes recurrences: a randomized clinical trial</title>
<author><name sortKey="Khemis, A" sort="Khemis, A" uniqKey="Khemis A" first="A." last="Khemis">A. Khemis</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de Dermatologie, Hôpital L’Archet 2, 151, route de Saint Antoine de Ginestière, 06202 Nice Cedex 3</wicri:regionArea>
<placeName><region type="region" nuts="2">Provence-Alpes-Côte d'Azur</region>
<settlement type="city">Nice</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Duteil, L" sort="Duteil, L" uniqKey="Duteil L" first="L." last="Duteil">L. Duteil</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de Dermatologie, Hôpital L’Archet 2, 151, route de Saint Antoine de Ginestière, 06202 Nice Cedex 3</wicri:regionArea>
<wicri:noRegion>06202 Nice Cedex 3</wicri:noRegion>
<wicri:noRegion>06202 Nice Cedex 3</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Coudert, A C" sort="Coudert, A C" uniqKey="Coudert A" first="A. C." last="Coudert">A. C. Coudert</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoires Carilène, 7, rue du Chant des Oiseaux, 78360 Montesson</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Montesson</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Tillet, Y" sort="Tillet, Y" uniqKey="Tillet Y" first="Y." last="Tillet">Y. Tillet</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>White‐Tillet Consultants & Experts 35, rue Franck Hémon, 77500 Chelles</wicri:regionArea>
<wicri:noRegion>77500 Chelles</wicri:noRegion>
<wicri:noRegion>77500 Chelles</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Dereure, O" sort="Dereure, O" uniqKey="Dereure O" first="O." last="Dereure">O. Dereure</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de Dermatologie, Hôpital Saint‐Eloi, 80 avenue A Fliche, 34295 Montpellier Cedex 5</wicri:regionArea>
<placeName><region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
<settlement type="city">Montpellier</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ortonne, J P" sort="Ortonne, J P" uniqKey="Ortonne J" first="J. P." last="Ortonne">J. P. Ortonne</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de Dermatologie, Hôpital L’Archet 2, 151, route de Saint Antoine de Ginestière, 06202 Nice Cedex 3</wicri:regionArea>
<wicri:noRegion>06202 Nice Cedex 3</wicri:noRegion>
<wicri:noRegion>06202 Nice Cedex 3</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><country wicri:rule="url">France</country>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Journal of the European Academy of Dermatology and Venereology</title>
<title level="j" type="alt">JOURNAL OF EUROPEAN ACADEMY DERMATOLOGY VENEREOLOGY</title>
<idno type="ISSN">0926-9959</idno>
<idno type="eISSN">1468-3083</idno>
<imprint><biblScope unit="vol">26</biblScope>
<biblScope unit="issue">10</biblScope>
<biblScope unit="page" from="1240">1240</biblScope>
<biblScope unit="page" to="1246">1246</biblScope>
<biblScope unit="page-count">7</biblScope>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2012-10">2012-10</date>
</imprint>
<idno type="ISSN">0926-9959</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0926-9959</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aciclovir</term>
<term>Aciclovir group</term>
<term>Acyclovir</term>
<term>Acyclovir cream</term>
<term>Antimicrob agents chemother</term>
<term>Antiviral</term>
<term>Antiviral activity</term>
<term>Authors journal</term>
<term>Baseline</term>
<term>Clinical scores</term>
<term>Dermatology</term>
<term>Endpoint</term>
<term>European academy</term>
<term>Functional symptoms</term>
<term>Herpes</term>
<term>Herpes episode</term>
<term>Herpes labialis</term>
<term>Herpes simplex labialis</term>
<term>Intensity score</term>
<term>Jeadv</term>
<term>Labial</term>
<term>Labial herpes</term>
<term>Labial recurrences</term>
<term>Labialis</term>
<term>Lesion</term>
<term>Lesion repair</term>
<term>Oedema</term>
<term>Oral lubricant solution</term>
<term>Oxygenated glycerol triesters</term>
<term>Pain intensity score</term>
<term>Penciclovir</term>
<term>Penciclovir cream</term>
<term>Percentage reduction</term>
<term>Placebo</term>
<term>Placebo group</term>
<term>Protective barrier</term>
<term>Randomized</term>
<term>Recurrence</term>
<term>Recurrent herpes labialis</term>
<term>Recurrent labial herpes</term>
<term>Secondary endpoints</term>
<term>Simplex</term>
<term>Subjective scores</term>
<term>Time point</term>
<term>Topical</term>
<term>Topical aciclovir</term>
<term>Topical aciclovir group</term>
<term>Topical therapy</term>
<term>Treatment groups</term>
<term>Unsightly appearance</term>
<term>Venereology</term>
<term>Venereology khemis</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>Aciclovir</term>
<term>Aciclovir group</term>
<term>Acyclovir</term>
<term>Acyclovir cream</term>
<term>Antimicrob agents chemother</term>
<term>Antiviral</term>
<term>Antiviral activity</term>
<term>Authors journal</term>
<term>Baseline</term>
<term>Clinical scores</term>
<term>Dermatology</term>
<term>Endpoint</term>
<term>European academy</term>
<term>Functional symptoms</term>
<term>Herpes</term>
<term>Herpes episode</term>
<term>Herpes labialis</term>
<term>Herpes simplex labialis</term>
<term>Intensity score</term>
<term>Jeadv</term>
<term>Labial</term>
<term>Labial herpes</term>
<term>Labial recurrences</term>
<term>Labialis</term>
<term>Lesion</term>
<term>Lesion repair</term>
<term>Oedema</term>
<term>Oral lubricant solution</term>
<term>Oxygenated glycerol triesters</term>
<term>Pain intensity score</term>
<term>Penciclovir</term>
<term>Penciclovir cream</term>
<term>Percentage reduction</term>
<term>Placebo</term>
<term>Placebo group</term>
<term>Protective barrier</term>
<term>Randomized</term>
<term>Recurrence</term>
<term>Recurrent herpes labialis</term>
<term>Recurrent labial herpes</term>
<term>Secondary endpoints</term>
<term>Simplex</term>
<term>Subjective scores</term>
<term>Time point</term>
<term>Topical</term>
<term>Topical aciclovir</term>
<term>Topical aciclovir group</term>
<term>Topical therapy</term>
<term>Treatment groups</term>
<term>Unsightly appearance</term>
<term>Venereology</term>
<term>Venereology khemis</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract">Background Topical or systemic antiviral drugs reduce the duration of herpes simplex virus 1 (HSV‐1) recurrences but may not alleviate functional symptoms.</div>
</front>
</TEI>
<affiliations><list><country><li>France</li>
</country>
<region><li>Languedoc-Roussillon</li>
<li>Occitanie (région administrative)</li>
<li>Provence-Alpes-Côte d'Azur</li>
<li>Île-de-France</li>
</region>
<settlement><li>Montesson</li>
<li>Montpellier</li>
<li>Nice</li>
</settlement>
</list>
<tree><country name="France"><region name="Provence-Alpes-Côte d'Azur"><name sortKey="Khemis, A" sort="Khemis, A" uniqKey="Khemis A" first="A." last="Khemis">A. Khemis</name>
</region>
<name sortKey="Coudert, A C" sort="Coudert, A C" uniqKey="Coudert A" first="A. C." last="Coudert">A. C. Coudert</name>
<name sortKey="Dereure, O" sort="Dereure, O" uniqKey="Dereure O" first="O." last="Dereure">O. Dereure</name>
<name sortKey="Duteil, L" sort="Duteil, L" uniqKey="Duteil L" first="L." last="Duteil">L. Duteil</name>
<name sortKey="Ortonne, J P" sort="Ortonne, J P" uniqKey="Ortonne J" first="J. P." last="Ortonne">J. P. Ortonne</name>
<name sortKey="Ortonne, J P" sort="Ortonne, J P" uniqKey="Ortonne J" first="J. P." last="Ortonne">J. P. Ortonne</name>
<name sortKey="Tillet, Y" sort="Tillet, Y" uniqKey="Tillet Y" first="Y." last="Tillet">Y. Tillet</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000083 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000083 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= EdenteV2 |flux= France |étape= Analysis |type= RBID |clé= ISTEX:1450E6DD7D7326D61875E2B7F534873A886626BC |texte= Evaluation of the efficacy and safety of a CS20® protective barrier gel containing OGT compared with topical aciclovir and placebo on functional and objective symptoms of labial herpes recurrences: a randomized clinical trial }}
This area was generated with Dilib version V0.6.32. |